drugset
drugset / Trial / NCT02953730

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

NCT02953730 ↗

Phase 4 Completed 9 enrolled Chinese Academy of Medical Sciences
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the trail is to study the pharmacokinetics of Pegylated Recombinant Human Granulocyte Stimulating Factor（PEG-rhG-CSF） in Children and Adolescents

Timeline

Start
2015-09
Primary completion
2016-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Pegfilgrastim Protein / enzyme biologic — —

Indications

acute lymphoblastic leukemia